ACCUTANE STEVENS-JOHNSON SYNDROME: In February 2010, Health Canada reported that it had received reports of severe skin reactions, including sometimes fatal reaction known as Stevens-Johnson Syndrome from Accutane. At least 66 reports of Accutane skin reactions were identified by Health Canada, including adults and children, with two of the cases…
The number of Yaz, Yasmin and Ocella lawsuits that are part of a mass tort docket in New Jersey has increased significantly since the product liability cases were consolidated in February. The number of Yaz lawsuits, Yasmin lawsuits and Ocella lawsuits centralized in Bergen County Superior Court has gone from…
The death of a woman who was hit by a car on a crosswalk at the Salt Lake City International Airport has prompted a lawsuit from the woman’s husband. The lawsuit claims that airport officials were aware of the “dangerous traffic situation” at the crosswalk but had done nothing to…
A sports bar in Austell, Ga., has agreed to pay $1 million to the widow of a man killed by a drunk driver who was allegedly over-served by the bar staff. The lawsuit claims that in October 2008, The Sports Grill served alcohol to William Paul Davis IV when he…
GlaxoSmithKline Plc has agreed to pay more than $1 billion to resolve more than 800 cases alleging its Paxil antidepressant caused birth defects in some users’ children, according to people familiar with the settlements. The settlements, which provide an average payout of more than $1.2 million to families of affected…
A settlement has been reached in a lawsuit filed against a pharmaceutical company by a Watertown woman who linked her prescribed use of Paxil to the death of her infant son, according to court files. Jennifer Berg of Watertown sued SmithKline Beecham, doing business as GlaxoSmithKline, in October 2007. The…
A lawsuit was filed against two northern railroad companies this week by the family of a Chicago woman who was hit by a train and killed. Katie Ann Lunn died in the train accident earlier this year when an Amtrak train hit her SUV, which was stopped on the tracks…
In treating diabetes, it might not matter much whether the Food and Drug Administration halts sales of the drug Avandia. An FDA committee of outside experts met last week to provide advice on whether any regulatory action — from stronger warnings to removal — is needed. The FDA has the…
The New York Times (7/16, B2, Jolly, Harris) reports that UK pharmaceutical maker GlaxoSmithKline announced on July 15 that “it would take a second-quarter charge of $2.36 billion related to legal cases involving its drugs Avandia [rosiglitazone] and Paxil [paroxetine].” This announcement comes one “day after an American medical advisory…
An FDA panel has made a recommendation to the agency that the controversial diabetes drug Avandia should either be taken off the market or its sales should be severely restricted. Avandia and its maker, GlaxoSmithKline, have recently come under fire for trial results that reveal that patients taking Avandia are…